Free Trial

Northrop Grumman (NOC) Financials

Northrop Grumman logo
$478.87 +3.55 (+0.75%)
As of 01:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Northrop Grumman

Annual Income Statements for Northrop Grumman

This table shows Northrop Grumman's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
4,174 2,056 4,896 7,005 3,189 2,248 3,229 2,869 2,043 1,990
Consolidated Net Income / (Loss)
4,174 2,056 4,896 7,005 3,189 2,248 3,229 2,869 2,043 1,990
Net Income / (Loss) Continuing Operations
4,174 2,056 4,896 7,005 3,189 2,248 3,229 2,869 2,043 1,990
Total Pre-Tax Income
5,016 2,346 5,836 8,938 3,728 2,548 3,742 4,229 2,681 2,790
Total Operating Income
4,370 2,537 3,601 5,651 4,065 3,969 3,780 3,218 3,277 3,076
Total Gross Profit
8,362 6,551 7,474 7,268 7,478 7,259 6,791 5,930 5,909 5,642
Total Revenue
41,033 39,290 36,602 35,667 36,799 33,841 30,095 26,004 24,706 23,526
Operating Revenue
41,033 39,290 36,602 35,667 36,799 33,841 30,095 26,004 24,706 23,526
Total Cost of Revenue
32,671 32,739 29,128 28,399 29,321 26,582 23,304 20,074 18,797 17,884
Operating Cost of Revenue
32,671 32,739 29,128 28,399 29,321 26,582 23,304 20,074 18,797 17,884
Total Operating Expenses
3,992 4,014 3,873 1,617 3,413 3,290 3,011 2,712 2,632 2,566
Selling, General & Admin Expense
3,992 4,014 3,873 3,597 3,413 3,290 3,011 2,712 2,632 2,566
Total Other Income / (Expense), net
646 -191 2,235 3,268 -337 -1,421 -38 1,011 -596 -286
Interest Expense
621 967 506 556 1,627 528 562 360 301 301
Other Income / (Expense), net
1,267 776 2,741 3,824 1,290 -893 524 1,371 -295 15
Income Tax Expense
842 290 940 1,933 539 300 513 1,360 638 800
Basic Earnings per Share
$28.39 $13.57 $31.61 $43.70 $19.08 $13.28 $18.59 $16.45 $11.42 $10.51
Weighted Average Basic Shares Outstanding
147M 151.50M 154.90M 160.30M 167.10M 169.30M 173.70M 174.40M 178.90M 189.40M
Diluted Earnings per Share
$28.34 $13.53 $31.47 $43.54 $19.03 $13.22 $18.49 $16.34 $11.32 $10.39
Weighted Average Diluted Shares Outstanding
147.30M 152M 155.60M 160.90M 167.60M 170M 174.60M 175.60M 180.50M 191.60M
Weighted Average Basic & Diluted Shares Outstanding
144.76M 150.04M 153.05M 312.20M 333.44M 167.64M -6.09B 176.10M 182.60M 189.30M
Cash Dividends to Common per Share
$8.05 $7.34 $6.76 $6.16 $5.67 $5.16 $4.70 $3.90 $3.50 $3.10

Quarterly Income Statements for Northrop Grumman

This table shows Northrop Grumman's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
481 1,264 1,026 940 944 -535 937 812 842 2,080 915
Consolidated Net Income / (Loss)
481 1,264 1,026 940 944 -535 937 812 842 2,080 915
Net Income / (Loss) Continuing Operations
481 1,264 1,026 940 944 -535 937 812 842 2,080 915
Total Pre-Tax Income
578 1,551 1,188 1,146 1,131 -757 1,118 987 998 2,452 1,090
Total Operating Income
573 1,089 1,120 1,090 1,071 -393 1,016 967 947 906 844
Total Gross Profit
1,580 1,932 2,106 2,191 2,133 485 2,041 2,040 1,985 1,824 1,818
Total Revenue
9,468 10,686 9,996 10,218 10,133 10,638 9,775 9,576 9,301 10,033 8,971
Operating Revenue
9,468 10,686 9,996 10,218 10,133 10,638 9,775 9,576 9,301 10,033 8,971
Total Cost of Revenue
7,888 8,754 7,890 8,027 8,000 10,153 7,734 7,536 7,316 8,209 7,153
Operating Cost of Revenue
7,888 8,754 7,890 8,027 8,000 10,153 7,734 7,536 7,316 8,209 7,153
Total Operating Expenses
1,007 843 986 1,101 1,062 878 1,025 1,073 1,038 918 974
Selling, General & Admin Expense
1,007 843 986 1,101 1,062 878 1,025 1,073 1,038 918 974
Total Other Income / (Expense), net
5.00 462 68 56 60 -364 102 20 51 1,546 246
Interest Expense
156 160 161 154 146 550 141 147 129 120 122
Other Income / (Expense), net
161 622 229 210 206 186 243 167 180 1,666 368
Income Tax Expense
97 287 162 206 187 -222 181 175 156 372 175
Basic Earnings per Share
$3.33 $8.66 $7.02 $6.37 $6.34 ($3.50) $6.20 $5.35 $5.52 $13.48 $5.92
Weighted Average Basic Shares Outstanding
144.60M 147M 146.20M 147.50M 148.90M 151.50M 151.20M 151.70M 152.60M 154.90M 154.60M
Diluted Earnings per Share
$3.32 $8.66 $7.00 $6.36 $6.32 ($3.49) $6.18 $5.34 $5.50 $13.42 $5.89
Weighted Average Diluted Shares Outstanding
144.90M 147.30M 146.50M 147.70M 149.30M 152M 151.70M 152.20M 153.20M 155.60M 155.30M
Weighted Average Basic & Diluted Shares Outstanding
143.93M 144.76M 145.70M 146.25M 147.99M 150.04M 150.79M 151.30M 151.86M 153.05M 153.91M
Cash Dividends to Common per Share
$2.06 $2.06 $2.06 $2.06 $1.87 $1.87 $1.87 $1.87 $1.73 $1.73 $1.73

Annual Cash Flow Statements for Northrop Grumman

This table details how cash moves in and out of Northrop Grumman's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
1,244 532 -953 -1,377 2,662 666 5,668 8,684 222 -1,544
Net Cash From Operating Activities
4,388 3,875 2,901 3,567 4,305 4,297 3,827 2,613 2,813 2,162
Net Cash From Continuing Operating Activities
4,388 3,875 2,901 3,567 4,305 4,823 3,827 2,613 2,813 2,162
Net Income / (Loss) Continuing Operations
4,174 2,056 4,896 7,005 3,189 2,248 3,229 2,869 2,043 1,990
Consolidated Net Income / (Loss)
4,174 2,056 4,896 7,005 3,189 2,248 3,229 2,869 2,043 1,990
Depreciation Expense
1,370 1,338 1,342 1,239 1,267 1,265 800 475 456 467
Non-Cash Adjustments To Reconcile Net Income
-848 1,613 -2,416 -5,461 -588 1,691 712 -485 918 -40
Changes in Operating Assets and Liabilities, net
-308 -1,132 -921 784 437 -381 -914 -246 -604 -255
Net Cash From Investing Activities
-1,749 -1,582 -1,241 2,058 -1,211 -1,207 -8,878 -889 -805 -431
Net Cash From Continuing Investing Activities
-1,749 -1,582 -1,241 2,058 -1,211 -1,207 6,436 -889 -805 -431
Purchase of Property, Plant & Equipment
-1,767 -1,775 -1,435 -1,415 -1,420 -1,264 -1,249 -928 -920 -471
Sale and/or Maturity of Investments
0.00 197 0.00 0.00 - - - - - -
Other Investing Activities, net
18 -4.00 194 73 209 57 28 39 115 40
Net Cash From Financing Activities
-1,395 -1,761 -2,613 -7,002 -432 -2,424 -4,595 6,960 -1,786 -3,275
Net Cash From Continuing Financing Activities
-1,395 -1,761 -2,613 -7,002 -432 -2,424 -4,595 6,960 -1,786 -3,275
Repayment of Debt
-132 -1,088 -7.00 -2,280 -1,162 -506 -2,426 -111 -195 96
Repurchase of Common Equity
-2,514 -1,500 -1,504 -3,705 -490 -744 -1,263 -393 -1,547 -3,182
Payment of Dividends
-1,186 -1,116 -1,052 -983 -953 -880 -821 -689 -640 -603
Issuance of Debt
2,495 1,995 0.00 0.00 2,239 -229 0.00 8,245 749 600
Other Financing Activities, net
-58 -52 -50 -34 -66 -65 -85 -92 -153 -186

Quarterly Cash Flow Statements for Northrop Grumman

This table details how cash moves in and out of Northrop Grumman's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
-2,668 1,027 54 211 -48 1,027 -1,302 889 -82 911 497
Net Cash From Operating Activities
-1,565 2,578 1,091 1,425 -706 2,430 1,228 919 -702 2,251 1,335
Net Cash From Continuing Operating Activities
-1,565 2,578 1,091 1,425 -706 2,430 1,228 919 -702 2,251 1,335
Net Income / (Loss) Continuing Operations
481 1,264 1,026 940 944 -535 937 812 842 2,080 915
Consolidated Net Income / (Loss)
481 1,264 1,026 940 944 -535 937 812 842 2,080 915
Depreciation Expense
337 414 331 326 299 400 317 323 298 382 327
Non-Cash Adjustments To Reconcile Net Income
-684 687 -561 -81 -893 1,930 -296 323 -344 -545 -593
Changes in Operating Assets and Liabilities, net
-1,699 213 295 240 -1,056 635 270 -539 -1,498 334 686
Net Cash From Investing Activities
-252 -798 -361 -321 -269 -770 -200 -303 -309 -578 -195
Net Cash From Continuing Investing Activities
-252 -798 -361 -321 -269 -770 -200 -303 -309 -578 -195
Purchase of Property, Plant & Equipment
-256 -816 -361 -320 -270 -803 -359 -304 -309 -632 -296
Sale and/or Maturity of Investments
0.00 - - - 0.00 40 157 - 0.00 - -
Other Investing Activities, net
4.00 18 - -1.00 1.00 -7.00 2.00 1.00 0.00 54 101
Net Cash From Financing Activities
-851 -753 -676 -893 927 -633 -2,330 273 929 -762 -643
Net Cash From Continuing Financing Activities
-851 -753 -676 -893 927 -633 -2,330 273 929 -762 -643
Repayment of Debt
-1,505 -12 -54 -26 -40 -4.00 -1,826 768 -26 -3.00 -3.00
Repurchase of Common Equity
-480 -441 -321 -562 -1,190 -346 -223 -208 -723 -493 -371
Payment of Dividends
-302 -299 -301 -303 -283 -282 -280 -284 -270 -266 -267
Issuance of Debt
1,474 - - - 2,495 - - - 1,995 - -
Other Financing Activities, net
-38 -1.00 - -2.00 -55 -1.00 -1.00 -3.00 -47 - -2.00

Annual Balance Sheets for Northrop Grumman

This table presents Northrop Grumman's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
49,359 46,544 43,755 42,579 44,469 41,089 37,653 35,128 25,614 24,424
Total Current Assets
14,274 13,706 12,488 12,426 15,344 10,685 9,680 16,587 6,856 6,334
Cash & Equivalents
4,353 3,109 2,577 3,530 4,907 2,245 1,579 11,225 2,541 2,319
Accounts Receivable
7,180 7,147 7,494 6,959 6,641 6,660 6,474 4,519 - -
Inventories, net
1,455 1,109 978 811 759 783 654 398 816 807
Other Current Assets
1,286 2,341 1,439 1,126 1,402 997 973 445 200 367
Plant, Property, & Equipment, net
10,536 9,653 8,800 7,894 7,071 6,912 6,372 4,225 3,588 3,064
Total Noncurrent Assets
24,549 23,185 22,467 22,259 22,054 23,492 21,601 14,316 15,170 15,026
Goodwill
17,512 17,517 17,516 17,515 17,518 18,708 18,672 12,455 12,450 12,460
Intangible Assets
254 305 384 578 783 1,040 1,372 52 - -
Noncurrent Deferred & Refundable Income Taxes
1,599 1,020 162 200 311 508 94 447 1,462 1,409
Employee Benefit Assets
2,184 1,331 - - - - - - - -
Other Noncurrent Operating Assets
3,000 3,012 4,405 3,966 3,442 3,236 1,463 1,362 1,258 1,157
Total Liabilities & Shareholders' Equity
49,359 46,544 43,755 42,579 44,469 41,089 37,653 35,128 25,614 24,424
Total Liabilities
34,069 31,749 28,443 29,653 33,890 32,270 29,466 27,996 20,355 18,902
Total Current Liabilities
14,128 11,942 11,587 9,530 9,580 9,434 8,274 7,092 5,630 5,457
Accounts Payable
2,599 2,110 2,587 2,197 1,806 2,226 2,182 1,661 1,554 1,282
Current Deferred Revenue
4,070 4,193 3,609 3,026 2,517 2,237 1,917 1,761 1,471 1,537
Current Employee Benefit Liabilities
2,271 2,251 2,057 1,993 1,997 1,865 1,676 1,382 1,342 1,195
Other Current Liabilities
5,188 3,388 3,334 2,314 3,002 3,106 2,499 2,288 1,263 1,443
Total Noncurrent Liabilities
19,941 19,807 16,856 20,123 24,310 22,836 21,192 20,904 14,725 13,445
Long-Term Debt
14,692 13,786 11,805 12,777 14,261 12,770 13,883 14,399 7,058 6,386
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 0.00 0.00 490 0.00 0.00 108 0.00 - -
Noncurrent Employee Benefit Liabilities
1,120 1,290 1,188 3,269 6,498 6,979 5,755 5,511 6,818 6,172
Other Noncurrent Operating Liabilities
4,129 4,731 3,863 3,587 3,551 3,087 1,446 994 849 887
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
15,290 14,795 15,312 12,926 10,579 8,819 8,187 7,132 5,259 5,522
Total Preferred & Common Equity
15,290 14,795 15,312 12,926 10,579 8,819 8,187 7,132 5,259 5,522
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
15,290 14,795 15,312 12,926 10,579 8,819 8,187 7,132 5,259 5,522
Common Stock
145 150 153 156 225 168 171 218 175 181
Retained Earnings
15,297 14,773 15,312 12,913 10,482 8,748 8,068 6,913 10,630 10,661
Accumulated Other Comprehensive Income / (Loss)
-152 -128 -153 -143 -128 -97 -52 1.00 -5,546 -5,320

Quarterly Balance Sheets for Northrop Grumman

This table presents Northrop Grumman's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
48,468 49,359 48,289 47,670 47,818 46,544 44,896 45,609 44,244 43,755 42,733
Total Current Assets
13,267 14,274 14,332 14,267 14,796 13,706 13,150 13,869 12,810 12,488 12,298
Cash & Equivalents
1,685 4,353 3,326 3,272 3,061 3,109 2,082 3,384 2,495 2,577 1,666
Accounts Receivable
8,662 7,180 1,609 8,128 8,282 7,147 8,034 7,966 8,276 7,494 8,366
Inventories, net
1,578 1,455 1,646 1,504 1,370 1,109 1,355 1,287 1,115 978 989
Other Current Assets
1,342 1,286 7,751 1,363 2,083 2,341 1,679 1,232 924 1,439 1,277
Plant, Property, & Equipment, net
10,522 10,536 10,078 9,771 9,690 9,653 9,173 8,976 8,838 8,800 8,325
Total Noncurrent Assets
24,679 24,549 23,879 23,632 23,332 23,185 22,573 22,764 22,596 22,467 22,110
Goodwill
17,434 17,512 17,517 17,516 17,515 17,517 17,514 17,517 17,516 17,516 17,516
Intangible Assets
242 254 268 282 290 305 324 344 364 384 433
Noncurrent Deferred & Refundable Income Taxes
1,633 1,599 1,407 1,250 1,123 1,020 330 452 234 162 233
Employee Benefit Assets
2,285 2,184 - - - 1,331 - - - - -
Other Noncurrent Operating Assets
3,085 3,000 4,687 4,584 4,404 3,012 4,405 4,451 4,482 4,405 3,928
Total Liabilities & Shareholders' Equity
48,468 49,359 48,289 47,670 47,818 46,544 44,896 45,609 44,244 43,755 42,733
Total Liabilities
33,484 34,069 33,541 33,369 33,595 31,749 28,968 30,123 29,108 28,443 28,790
Total Current Liabilities
13,969 14,128 13,101 12,908 13,132 11,942 10,305 11,557 10,483 11,587 10,812
Accounts Payable
2,501 2,599 2,518 2,352 2,580 2,110 2,260 2,056 2,136 2,587 2,335
Current Deferred Revenue
3,710 4,070 3,157 3,292 3,530 4,193 3,458 3,397 3,211 3,609 3,107
Current Employee Benefit Liabilities
1,598 2,271 1,924 1,903 1,701 2,251 1,927 1,878 1,646 2,057 1,831
Other Current Liabilities
6,160 5,188 5,502 5,361 5,321 3,388 2,660 4,226 3,490 3,334 3,539
Total Noncurrent Liabilities
19,515 19,941 20,440 20,461 20,463 19,807 18,663 18,566 18,625 16,856 17,978
Long-Term Debt
14,167 14,692 14,689 14,706 14,742 13,786 13,793 13,796 13,770 11,805 11,803
Noncurrent Employee Benefit Liabilities
1,115 1,120 1,186 1,211 1,250 1,290 1,147 1,161 1,173 1,188 2,405
Other Noncurrent Operating Liabilities
4,233 4,129 4,565 4,544 4,471 4,731 3,723 3,609 3,682 3,863 3,684
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
14,984 15,290 14,748 14,301 14,223 14,795 15,928 15,486 15,136 15,312 13,943
Total Preferred & Common Equity
14,984 15,290 14,748 14,301 14,223 14,795 15,928 15,486 15,136 15,312 13,943
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
14,984 15,290 14,748 14,301 14,223 14,795 15,928 15,486 15,136 15,312 13,943
Common Stock
144 145 146 146 148 150 151 151 152 153 154
Retained Earnings
14,982 15,297 14,738 14,301 14,218 14,773 15,924 15,485 15,135 15,312 13,955
Accumulated Other Comprehensive Income / (Loss)
-142 -152 -136 -146 -143 -128 -147 -150 -151 -153 -166

Annual Metrics And Ratios for Northrop Grumman

This table displays calculated financial ratios and metrics derived from Northrop Grumman's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
4.44% 7.34% 2.62% -3.08% 8.74% 12.45% 15.73% 5.25% 5.02% -1.89%
EBITDA Growth
50.66% -39.47% -28.28% 61.79% 52.55% -14.95% 0.79% 47.29% -3.37% -3.34%
EBIT Growth
70.15% -47.76% -33.07% 76.94% 74.09% -28.53% -6.21% 53.89% -3.53% -3.98%
NOPAT Growth
63.55% -26.40% -31.79% 27.37% -0.70% 7.35% 49.41% -12.58% 13.82% -2.55%
Net Income Growth
103.02% -58.01% -30.11% 119.66% 41.86% -30.38% 12.55% 40.43% 2.66% -3.82%
EPS Growth
109.46% -57.01% -27.72% 128.80% 43.95% -28.50% 13.16% 44.35% 8.95% 6.56%
Operating Cash Flow Growth
13.24% 33.57% -18.67% -17.14% 0.19% 12.28% 46.46% -7.11% 30.11% -16.62%
Free Cash Flow Firm Growth
169.43% 97.46% -19.45% -80.97% -8.25% 167.15% -518.79% -28.44% 21.46% -56.30%
Invested Capital Growth
0.62% 3.80% 10.68% 19.49% -4.07% -5.60% 98.83% 5.42% 1.95% 3.14%
Revenue Q/Q Growth
0.12% 1.56% 3.96% -4.22% 4.22% 1.70% 5.63% -0.17% 3.78% -1.73%
EBITDA Q/Q Growth
38.07% -37.25% -9.62% 21.94% 41.50% -17.31% -20.62% 38.97% -3.29% -2.23%
EBIT Q/Q Growth
51.57% -45.62% -12.05% 25.78% 56.72% -24.24% -25.07% 43.99% -3.65% -2.49%
NOPAT Q/Q Growth
43.57% -31.07% 7.03% -6.82% 0.04% 8.34% 24.72% -18.41% 7.24% -1.84%
Net Income Q/Q Growth
75.75% -55.98% -11.40% 51.46% 30.16% -25.39% -17.08% 29.47% -4.26% -2.31%
EPS Q/Q Growth
75.05% -55.55% -10.37% 52.99% 29.81% -25.31% -16.79% 29.58% -3.41% 0.00%
Operating Cash Flow Q/Q Growth
3.49% 4.84% 38.67% -4.29% -16.68% 2.07% 25.19% 3.00% -3.50% 7.08%
Free Cash Flow Firm Q/Q Growth
-14.32% 487.29% 158.32% -81.33% -30.91% 81.16% 16.66% -42.69% 10.03% -50.34%
Invested Capital Q/Q Growth
-1.85% -7.84% 1.91% 10.12% -5.96% -13.76% -5.85% -4.94% -11.54% -11.39%
Profitability Metrics
- - - - - - - - - -
Gross Margin
20.38% 16.67% 20.42% 20.38% 20.32% 21.45% 22.57% 22.80% 23.92% 23.98%
EBITDA Margin
17.08% 11.84% 20.99% 30.04% 18.00% 12.83% 16.96% 19.47% 13.92% 15.12%
Operating Margin
10.65% 6.46% 9.84% 15.84% 11.05% 11.73% 12.56% 12.38% 13.26% 13.07%
EBIT Margin
13.74% 8.43% 17.33% 26.57% 14.55% 9.09% 14.30% 17.65% 12.07% 13.14%
Profit (Net Income) Margin
10.17% 5.23% 13.38% 19.64% 8.67% 6.64% 10.73% 11.03% 8.27% 8.46%
Tax Burden Percent
83.21% 87.64% 83.89% 78.37% 85.54% 88.23% 86.29% 67.84% 76.20% 71.33%
Interest Burden Percent
88.98% 70.81% 92.02% 94.33% 69.62% 82.83% 86.94% 92.16% 89.91% 90.26%
Effective Tax Rate
16.79% 12.36% 16.11% 21.63% 14.46% 11.77% 13.71% 32.16% 23.80% 28.67%
Return on Invested Capital (ROIC)
14.23% 8.89% 12.93% 21.75% 18.35% 17.58% 21.18% 21.74% 25.79% 23.23%
ROIC Less NNEP Spread (ROIC-NNEP)
19.35% 7.21% 33.23% 51.66% 15.23% 6.60% 20.76% 39.58% 15.21% 16.58%
Return on Net Nonoperating Assets (RNNOA)
13.52% 4.77% 21.74% 37.86% 14.53% 8.86% 20.97% 24.57% 12.11% 7.96%
Return on Equity (ROE)
27.75% 13.66% 34.68% 59.60% 32.88% 26.44% 42.16% 46.31% 37.90% 31.20%
Cash Return on Invested Capital (CROIC)
13.62% 5.16% 2.80% 3.99% 22.51% 23.34% -44.96% 16.46% 23.86% 20.14%
Operating Return on Assets (OROA)
11.76% 7.34% 14.69% 21.77% 12.52% 7.81% 11.83% 15.11% 11.92% 12.12%
Return on Assets (ROA)
8.70% 4.55% 11.34% 16.09% 7.45% 5.71% 8.87% 9.45% 8.17% 7.80%
Return on Common Equity (ROCE)
27.75% 13.66% 34.68% 59.60% 32.88% 26.44% 42.16% 46.31% 37.90% 31.20%
Return on Equity Simple (ROE_SIMPLE)
27.30% 13.90% 31.97% 54.19% 30.14% 25.49% 39.44% 40.23% 38.85% 36.04%
Net Operating Profit after Tax (NOPAT)
3,636 2,223 3,021 4,429 3,477 3,502 3,262 2,183 2,497 2,194
NOPAT Margin
8.86% 5.66% 8.25% 12.42% 9.45% 10.35% 10.84% 8.40% 10.11% 9.33%
Net Nonoperating Expense Percent (NNEP)
-5.12% 1.68% -20.30% -29.91% 3.12% 10.98% 0.42% -17.84% 10.58% 6.66%
Return On Investment Capital (ROIC_SIMPLE)
12.13% 7.78% 11.14% 17.23% 14.00% 16.22% 14.78% 10.14% 20.27% 18.42%
Cost of Revenue to Revenue
79.62% 83.33% 79.58% 79.62% 79.68% 78.55% 77.43% 77.20% 76.08% 76.02%
SG&A Expenses to Revenue
9.73% 10.22% 10.58% 10.09% 9.27% 9.72% 10.01% 10.43% 10.65% 10.91%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
9.73% 10.22% 10.58% 4.53% 9.27% 9.72% 10.01% 10.43% 10.65% 10.91%
Earnings before Interest and Taxes (EBIT)
5,637 3,313 6,342 9,475 5,355 3,076 4,304 4,589 2,982 3,091
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7,007 4,651 7,684 10,714 6,622 4,341 5,104 5,064 3,438 3,558
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
4.45 4.67 5.28 4.51 4.48 6.03 4.69 6.66 6.83 5.38
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.66 1.76 2.21 1.63 1.29 1.57 1.28 1.83 1.45 1.26
Price to Earnings (P/E)
16.31 33.62 16.52 8.32 14.86 23.65 11.89 16.55 17.58 14.92
Dividend Yield
1.72% 1.60% 1.29% 1.68% 1.99% 1.64% 2.13% 1.43% 1.72% 1.90%
Earnings Yield
6.13% 2.97% 6.05% 12.02% 6.73% 4.23% 8.41% 6.04% 5.69% 6.70%
Enterprise Value to Invested Capital (EV/IC)
3.06 3.13 3.67 3.04 3.06 3.29 2.47 4.92 4.14 3.52
Enterprise Value to Revenue (EV/Rev)
1.91 2.03 2.46 1.89 1.54 1.88 1.68 1.95 1.64 1.43
Enterprise Value to EBITDA (EV/EBITDA)
11.19 17.16 11.73 6.30 8.57 14.67 9.93 10.01 11.76 9.49
Enterprise Value to EBIT (EV/EBIT)
13.91 24.08 14.21 7.12 10.60 20.71 11.78 11.04 13.56 10.92
Enterprise Value to NOPAT (EV/NOPAT)
21.56 35.89 29.83 15.24 16.32 18.19 15.54 23.21 16.19 15.38
Enterprise Value to Operating Cash Flow (EV/OCF)
17.87 20.59 31.06 18.93 13.18 14.82 13.25 19.39 14.37 15.61
Enterprise Value to Free Cash Flow (EV/FCFF)
22.53 61.79 137.80 83.15 13.30 13.70 0.00 30.65 17.50 17.75
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.96 0.93 0.77 0.99 1.35 1.45 1.70 2.02 1.34 1.16
Long-Term Debt to Equity
0.96 0.93 0.77 0.99 1.35 1.45 1.70 2.02 1.34 1.16
Financial Leverage
0.70 0.66 0.65 0.73 0.95 1.34 1.01 0.62 0.80 0.48
Leverage Ratio
3.19 3.00 3.06 3.70 4.41 4.63 4.75 4.90 4.64 4.00
Compound Leverage Factor
2.84 2.12 2.81 3.49 3.07 3.84 4.13 4.52 4.17 3.61
Debt to Total Capital
49.00% 48.23% 43.53% 49.71% 57.41% 59.15% 62.90% 66.88% 57.30% 53.63%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
49.00% 48.23% 43.53% 49.71% 57.41% 59.15% 62.90% 66.88% 57.30% 53.63%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
51.00% 51.77% 56.47% 50.29% 42.59% 40.85% 37.10% 33.12% 42.70% 46.37%
Debt to EBITDA
2.10 2.96 1.54 1.19 2.15 2.94 2.72 2.84 2.05 1.79
Net Debt to EBITDA
1.48 2.30 1.20 0.86 1.41 2.42 2.41 0.63 1.31 1.14
Long-Term Debt to EBITDA
2.10 2.96 1.54 1.19 2.15 2.94 2.72 2.84 2.05 1.79
Debt to NOPAT
4.04 6.20 3.91 2.88 4.10 3.65 4.26 6.60 2.83 2.91
Net Debt to NOPAT
2.84 4.80 3.05 2.09 2.69 3.01 3.77 1.45 1.81 1.85
Long-Term Debt to NOPAT
4.04 6.20 3.91 2.88 4.10 3.65 4.26 6.60 2.83 2.91
Altman Z-Score
2.84 2.88 3.54 3.26 2.55 2.39 2.30 2.79 3.05 2.98
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.01 1.15 1.08 1.30 1.60 1.13 1.17 2.34 1.22 1.16
Quick Ratio
0.82 0.86 0.87 1.10 1.21 0.94 0.97 2.22 1.04 0.95
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3,479 1,291 654 812 4,265 4,649 -6,923 1,653 2,310 1,902
Operating Cash Flow to CapEx
248.33% 218.31% 202.16% 252.08% 303.17% 339.95% 306.41% 281.57% 305.76% 459.02%
Free Cash Flow to Firm to Interest Expense
5.60 1.34 1.29 1.46 2.62 8.80 -12.32 4.59 7.68 6.32
Operating Cash Flow to Interest Expense
7.07 4.01 5.73 6.42 2.65 8.14 6.81 7.26 9.35 7.18
Operating Cash Flow Less CapEx to Interest Expense
4.22 2.17 2.90 3.87 1.77 5.74 4.59 4.68 6.29 5.62
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.86 0.87 0.85 0.82 0.86 0.86 0.83 0.86 0.99 0.92
Accounts Receivable Turnover
5.73 5.37 5.07 5.25 5.53 5.15 5.48 0.00 0.00 0.00
Inventory Turnover
25.48 31.37 32.56 36.18 38.03 37.00 44.30 33.07 23.16 23.09
Fixed Asset Turnover
4.06 4.26 4.39 4.77 5.26 5.10 5.68 6.66 7.43 7.77
Accounts Payable Turnover
13.88 13.94 12.18 14.19 14.54 12.06 12.13 12.49 13.26 13.83
Days Sales Outstanding (DSO)
63.72 68.01 72.06 69.59 65.96 70.83 66.66 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
14.32 11.63 11.21 10.09 9.60 9.87 8.24 11.04 15.76 15.81
Days Payable Outstanding (DPO)
26.30 26.18 29.97 25.72 25.10 30.26 30.10 29.23 27.53 26.40
Cash Conversion Cycle (CCC)
51.74 53.46 53.30 53.95 50.47 50.43 44.81 -18.19 -11.78 -10.59
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
25,629 25,472 24,540 22,173 18,556 19,344 20,491 10,306 9,776 9,589
Invested Capital Turnover
1.61 1.57 1.57 1.75 1.94 1.70 1.95 2.59 2.55 2.49
Increase / (Decrease) in Invested Capital
157 932 2,367 3,617 -788 -1,147 10,185 530 187 292
Enterprise Value (EV)
78,407 79,792 90,119 67,507 56,738 63,700 50,696 50,668 40,436 33,752
Market Capitalization
68,068 69,115 80,891 58,260 47,384 53,175 38,392 47,494 35,919 29,685
Book Value per Share
$104.95 $98.11 $99.49 $81.53 $63.46 $52.33 $47.15 $40.97 $29.84 $30.28
Tangible Book Value per Share
($16.99) ($20.07) ($16.81) ($32.59) ($46.32) ($64.85) ($68.29) ($30.88) ($40.80) ($38.04)
Total Capital
29,982 28,581 27,117 25,703 24,840 21,589 22,070 21,531 12,317 11,908
Total Debt
14,692 13,786 11,805 12,777 14,261 12,770 13,883 14,399 7,058 6,386
Total Long-Term Debt
14,692 13,786 11,805 12,777 14,261 12,770 13,883 14,399 7,058 6,386
Net Debt
10,339 10,677 9,228 9,247 9,354 10,525 12,304 3,174 4,517 4,067
Capital Expenditures (CapEx)
1,767 1,775 1,435 1,415 1,420 1,264 1,249 928 920 471
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-4,207 -1,345 -1,676 -634 857 -994 -173 -1,730 -1,315 -1,442
Debt-free Net Working Capital (DFNWC)
146 1,764 901 2,896 5,764 1,251 1,406 9,495 1,226 877
Net Working Capital (NWC)
146 1,764 901 2,896 5,764 1,251 1,406 9,495 1,226 877
Net Nonoperating Expense (NNE)
-538 167 -1,875 -2,576 288 1,254 33 -686 454 204
Net Nonoperating Obligations (NNO)
10,339 10,677 9,228 9,247 7,977 10,525 12,304 3,174 4,517 4,067
Total Depreciation and Amortization (D&A)
1,370 1,338 1,342 1,239 1,267 1,265 800 475 456 467
Debt-free, Cash-free Net Working Capital to Revenue
-10.25% -3.42% -4.58% -1.78% 2.33% -2.94% -0.57% -6.65% -5.32% -6.13%
Debt-free Net Working Capital to Revenue
0.36% 4.49% 2.46% 8.12% 15.66% 3.70% 4.67% 36.51% 4.96% 3.73%
Net Working Capital to Revenue
0.36% 4.49% 2.46% 8.12% 15.66% 3.70% 4.67% 36.51% 4.96% 3.73%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$28.39 $13.57 $31.61 $43.70 $19.08 $13.28 $18.59 $11.55 $12.30 $10.51
Adjusted Weighted Average Basic Shares Outstanding
147M 151.50M 154.90M 160.30M 167.10M 169.30M 173.70M 174.40M 178.90M 189.40M
Adjusted Diluted Earnings per Share
$28.34 $13.53 $31.47 $43.54 $19.03 $13.22 $18.49 $11.47 $12.19 $10.39
Adjusted Weighted Average Diluted Shares Outstanding
147.30M 152M 155.60M 160.90M 167.60M 170M 174.60M 175.60M 180.50M 191.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
144.76M 150.04M 153.05M 156.10M 166.72M 167.64M 169.74M 174.09M 174.60M 180.94M
Normalized Net Operating Profit after Tax (NOPAT)
3,636 2,223 3,021 2,877 3,477 3,502 3,262 2,183 2,497 2,194
Normalized NOPAT Margin
8.86% 5.66% 8.25% 8.07% 9.45% 10.35% 10.84% 8.40% 10.11% 9.33%
Pre Tax Income Margin
12.22% 5.97% 15.94% 25.06% 10.13% 7.53% 12.43% 16.26% 10.85% 11.86%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
9.08 3.43 12.53 17.04 3.29 5.83 7.66 12.75 9.91 10.27
NOPAT to Interest Expense
5.86 2.30 5.97 7.97 2.14 6.63 5.80 6.06 8.30 7.29
EBIT Less CapEx to Interest Expense
6.23 1.59 9.70 14.50 2.42 3.43 5.44 10.17 6.85 8.70
NOPAT Less CapEx to Interest Expense
3.01 0.46 3.13 5.42 1.26 4.24 3.58 3.49 5.24 5.72
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
28.41% 54.28% 21.49% 14.03% 29.88% 39.15% 25.43% 24.02% 31.33% 30.30%
Augmented Payout Ratio
88.64% 127.24% 52.21% 66.92% 45.25% 72.24% 64.54% 37.71% 107.05% 190.20%

Quarterly Metrics And Ratios for Northrop Grumman

This table displays calculated financial ratios and metrics derived from Northrop Grumman's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-6.56% 0.45% 2.26% 6.70% 8.95% 6.03% 8.96% 8.81% 5.73% 16.14% 2.88%
EBITDA Growth
-32.04% 1,001.04% 6.60% 11.60% 10.60% -93.47% 2.40% -9.56% -9.81% -21.69% -10.58%
EBIT Growth
-42.52% 926.57% 7.15% 14.64% 13.31% -108.05% 3.88% -11.48% -11.75% -25.25% -13.86%
NOPAT Growth
-46.66% 422.61% 13.59% 12.38% 11.88% -135.79% 20.19% 1.37% 6.70% 27.85% -18.52%
Net Income Growth
-49.05% 336.26% 9.50% 15.76% 12.11% -125.72% 2.40% -14.16% -11.83% -23.25% -13.92%
EPS Growth
-47.47% 348.14% 13.27% 19.10% 14.91% -126.01% 4.92% -11.88% -9.84% -21.34% -11.16%
Operating Cash Flow Growth
-121.67% 6.09% -11.16% 55.06% -0.57% 7.95% -8.02% 566.50% -43.85% 56.10% 14.79%
Free Cash Flow Firm Growth
-177.46% 160.52% 192.16% 395.01% 183.69% 24.48% 16.32% 104.71% 51.01% 47.00% -794.95%
Invested Capital Growth
6.03% 0.62% -5.53% -0.63% -1.92% 3.80% 14.78% 2.30% 10.33% 10.68% 19.59%
Revenue Q/Q Growth
-11.40% 6.90% -2.17% 0.84% -4.75% 8.83% 2.08% 2.96% -7.30% 11.84% 1.93%
EBITDA Q/Q Growth
-49.60% 26.49% 3.32% 3.17% 716.58% -87.75% 8.17% 2.25% -51.76% 91.94% -4.47%
EBIT Q/Q Growth
-57.10% 26.83% 3.77% 1.80% 716.91% -116.44% 11.02% 0.62% -56.18% 112.21% -5.39%
NOPAT Q/Q Growth
-46.27% -8.25% 8.19% 0.02% 424.94% -132.31% 7.04% -0.43% 3.96% 8.48% -9.72%
Net Income Q/Q Growth
-61.95% 23.20% 9.15% -0.42% 276.45% -157.10% 15.39% -3.56% -59.52% 127.32% -3.28%
EPS Q/Q Growth
-61.66% 23.71% 10.06% 0.63% 281.09% -156.47% 15.73% -2.91% -59.02% 127.84% -2.81%
Operating Cash Flow Q/Q Growth
-160.71% 136.30% -23.44% 301.84% -129.05% 97.88% 33.62% 230.91% -131.19% 68.61% 777.67%
Free Cash Flow Firm Q/Q Growth
-248.55% -70.73% 136.06% -24.54% 216.06% 55.42% -1,367.87% 112.76% -4.73% 50.60% 28.67%
Invested Capital Q/Q Growth
7.17% -1.85% 1.46% -0.65% 1.70% -7.84% 6.72% -1.94% 7.62% 1.91% -4.88%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
16.69% 18.08% 21.07% 21.44% 21.05% 4.56% 20.88% 21.30% 21.34% 18.18% 20.27%
EBITDA Margin
11.31% 19.89% 16.81% 15.91% 15.55% 1.81% 16.12% 15.22% 15.32% 29.44% 17.16%
Operating Margin
6.05% 10.19% 11.20% 10.67% 10.57% -3.69% 10.39% 10.10% 10.18% 9.03% 9.41%
EBIT Margin
7.75% 16.01% 13.50% 12.72% 12.60% -1.95% 12.88% 11.84% 12.12% 25.64% 13.51%
Profit (Net Income) Margin
5.08% 11.83% 10.26% 9.20% 9.32% -5.03% 9.59% 8.48% 9.05% 20.73% 10.20%
Tax Burden Percent
83.22% 81.50% 86.36% 82.02% 83.47% 70.67% 83.81% 82.27% 84.37% 84.83% 83.95%
Interest Burden Percent
78.75% 90.65% 88.07% 88.15% 88.57% 365.70% 88.80% 87.04% 88.55% 95.33% 89.93%
Effective Tax Rate
16.78% 18.50% 13.64% 17.98% 16.53% 0.00% 16.19% 17.73% 15.63% 15.17% 16.06%
Return on Invested Capital (ROIC)
7.62% 13.34% 14.76% 13.82% 13.53% -4.06% 13.03% 12.29% 12.66% 12.00% 12.58%
ROIC Less NNEP Spread (ROIC-NNEP)
7.65% 16.92% 15.27% 14.24% 13.97% -6.67% 13.81% 12.44% 13.05% 26.20% 14.77%
Return on Net Nonoperating Assets (RNNOA)
6.33% 11.82% 11.48% 10.44% 10.92% -4.41% 10.10% 9.42% 10.07% 17.14% 10.98%
Return on Equity (ROE)
13.95% 25.16% 26.24% 24.26% 24.45% -8.48% 23.14% 21.71% 22.73% 29.15% 23.56%
Cash Return on Invested Capital (CROIC)
6.21% 13.62% 15.11% 9.98% 10.79% 5.16% -1.29% 9.76% 2.37% 2.80% -5.07%
Operating Return on Assets (OROA)
6.50% 13.70% 11.87% 11.12% 10.98% -1.69% 11.37% 10.25% 10.44% 21.74% 11.18%
Return on Assets (ROA)
4.26% 10.12% 9.03% 8.04% 8.12% -4.38% 8.46% 7.34% 7.80% 17.58% 8.44%
Return on Common Equity (ROCE)
13.95% 25.16% 26.24% 24.26% 24.45% -8.48% 23.14% 21.71% 22.73% 29.15% 23.56%
Return on Equity Simple (ROE_SIMPLE)
24.77% 0.00% 16.10% 15.98% 15.17% 0.00% 29.33% 30.02% 31.60% 0.00% 39.63%
Net Operating Profit after Tax (NOPAT)
477 887 967 894 894 -275 852 796 799 769 708
NOPAT Margin
5.04% 8.31% 9.68% 8.75% 8.82% -2.59% 8.71% 8.31% 8.59% 7.66% 7.90%
Net Nonoperating Expense Percent (NNEP)
-0.03% -3.58% -0.51% -0.42% -0.44% 2.61% -0.78% -0.15% -0.39% -14.20% -2.19%
Return On Investment Capital (ROIC_SIMPLE)
1.64% 2.96% 3.29% 3.08% 3.09% -0.96% 2.87% 2.72% 2.76% 2.83% 2.75%
Cost of Revenue to Revenue
83.31% 81.92% 78.93% 78.56% 78.95% 95.44% 79.12% 78.70% 78.66% 81.82% 79.73%
SG&A Expenses to Revenue
10.64% 7.89% 9.86% 10.78% 10.48% 8.25% 10.49% 11.21% 11.16% 9.15% 10.86%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
10.64% 7.89% 9.86% 10.78% 10.48% 8.25% 10.49% 11.21% 11.16% 9.15% 10.86%
Earnings before Interest and Taxes (EBIT)
734 1,711 1,349 1,300 1,277 -207 1,259 1,134 1,127 2,572 1,212
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,071 2,125 1,680 1,626 1,576 193 1,576 1,457 1,425 2,954 1,539
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.95 4.45 5.19 4.45 4.99 4.67 4.08 4.34 4.51 5.28 5.01
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.84 1.66 1.87 1.56 1.77 1.76 1.68 1.77 1.84 2.21 1.98
Price to Earnings (P/E)
19.97 16.31 32.24 27.87 32.88 33.62 13.90 14.46 14.28 16.52 12.64
Dividend Yield
1.61% 1.72% 1.50% 1.78% 1.59% 1.60% 1.68% 1.60% 1.55% 1.29% 1.46%
Earnings Yield
5.01% 6.13% 3.10% 3.59% 3.04% 2.97% 7.19% 6.92% 7.00% 6.05% 7.91%
Enterprise Value to Invested Capital (EV/IC)
3.15 3.06 3.37 2.92 3.19 3.13 2.77 3.00 3.01 3.67 3.32
Enterprise Value to Revenue (EV/Rev)
2.15 1.91 2.15 1.84 2.06 2.03 1.98 2.05 2.15 2.46 2.27
Enterprise Value to EBITDA (EV/EBITDA)
13.32 11.19 17.32 15.12 17.21 17.16 10.34 10.52 10.57 11.73 9.41
Enterprise Value to EBIT (EV/EBIT)
17.00 13.91 23.64 20.71 23.86 24.08 12.58 12.84 12.85 14.21 11.09
Enterprise Value to NOPAT (EV/NOPAT)
26.90 21.56 34.71 31.15 35.68 35.89 23.77 25.19 25.94 29.83 28.34
Enterprise Value to Operating Cash Flow (EV/OCF)
24.54 17.87 20.74 17.17 21.35 20.59 20.74 20.41 29.62 31.06 38.24
Enterprise Value to Free Cash Flow (EV/FCFF)
52.24 22.53 21.65 29.17 29.27 61.79 0.00 31.05 133.54 137.80 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.95 0.96 1.00 1.03 1.04 0.93 0.87 0.89 0.91 0.77 0.85
Long-Term Debt to Equity
0.95 0.96 1.00 1.03 1.04 0.93 0.87 0.89 0.91 0.77 0.85
Financial Leverage
0.83 0.70 0.75 0.73 0.78 0.66 0.73 0.76 0.77 0.65 0.74
Leverage Ratio
3.30 3.19 3.04 3.13 3.14 3.00 2.93 3.00 3.03 3.06 3.35
Compound Leverage Factor
2.60 2.89 2.68 2.76 2.78 10.97 2.61 2.61 2.68 2.91 3.02
Debt to Total Capital
48.60% 49.00% 49.90% 50.70% 50.90% 48.23% 46.41% 47.11% 47.64% 43.53% 45.84%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
48.60% 49.00% 49.90% 50.70% 50.90% 48.23% 46.41% 47.11% 47.64% 43.53% 45.84%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
51.40% 51.00% 50.10% 49.30% 49.10% 51.77% 53.59% 52.89% 52.36% 56.47% 54.16%
Debt to EBITDA
2.18 2.10 2.89 2.96 3.07 2.96 1.86 1.87 1.83 1.54 1.39
Net Debt to EBITDA
1.92 1.48 2.24 2.30 2.43 2.30 1.58 1.41 1.50 1.20 1.19
Long-Term Debt to EBITDA
2.18 2.10 2.89 2.96 3.07 2.96 1.86 1.87 1.83 1.54 1.39
Debt to NOPAT
4.40 4.04 5.80 6.10 6.36 6.20 4.28 4.48 4.49 3.91 4.18
Net Debt to NOPAT
3.88 2.84 4.49 4.74 5.04 4.80 3.63 3.38 3.67 3.05 3.59
Long-Term Debt to NOPAT
4.40 4.04 5.80 6.10 6.36 6.20 4.28 4.48 4.49 3.91 4.18
Altman Z-Score
2.63 2.58 2.77 2.54 2.65 2.63 2.87 2.79 2.87 3.25 2.87
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.95 1.01 1.09 1.11 1.13 1.15 1.28 1.20 1.22 1.08 1.14
Quick Ratio
0.74 0.82 0.38 0.88 0.86 0.86 0.98 0.98 1.03 0.87 0.93
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,085 730 2,495 1,057 1,401 -1,207 -2,707 214 -1,674 -1,598 -3,236
Operating Cash Flow to CapEx
-611.33% 315.93% 302.22% 445.31% -261.48% 302.62% 342.06% 302.30% -227.18% 356.17% 451.01%
Free Cash Flow to Firm to Interest Expense
-6.96 4.57 15.50 6.86 9.60 -2.19 -19.20 1.45 -12.98 -13.32 -26.52
Operating Cash Flow to Interest Expense
-10.03 16.11 6.78 9.25 -4.84 4.42 8.71 6.25 -5.44 18.76 10.94
Operating Cash Flow Less CapEx to Interest Expense
-11.67 11.01 4.53 7.18 -6.68 2.96 6.16 4.18 -7.84 13.49 8.52
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.84 0.86 0.88 0.87 0.87 0.87 0.88 0.87 0.86 0.85 0.83
Accounts Receivable Turnover
4.76 5.73 8.50 5.07 4.85 5.37 4.72 4.57 4.61 5.07 4.51
Inventory Turnover
22.09 25.48 22.71 24.30 26.90 31.37 26.28 27.52 30.23 32.56 30.10
Fixed Asset Turnover
3.99 4.06 4.26 4.35 4.33 4.26 4.42 4.43 4.40 4.39 4.51
Accounts Payable Turnover
12.82 13.88 14.26 15.39 14.17 13.94 13.40 14.55 14.10 12.18 12.40
Days Sales Outstanding (DSO)
76.60 63.72 42.94 72.05 75.32 68.01 77.37 79.80 79.22 72.06 81.02
Days Inventory Outstanding (DIO)
16.52 14.32 16.08 15.02 13.57 11.63 13.89 13.26 12.07 11.21 12.13
Days Payable Outstanding (DPO)
28.48 26.30 25.59 23.72 25.75 26.18 27.23 25.09 25.88 29.97 29.45
Cash Conversion Cycle (CCC)
64.65 51.74 33.42 63.35 63.13 53.46 64.03 67.97 65.41 53.30 63.70
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
27,466 25,629 26,111 25,735 25,904 25,472 27,639 25,898 26,411 24,540 24,080
Invested Capital Turnover
1.51 1.61 1.53 1.58 1.53 1.57 1.50 1.48 1.47 1.57 1.59
Increase / (Decrease) in Invested Capital
1,562 157 -1,528 -163 -507 932 3,559 582 2,473 2,367 3,944
Enterprise Value (EV)
86,598 78,407 87,923 75,140 82,639 79,792 76,659 77,620 79,595 90,119 79,996
Market Capitalization
74,116 68,068 76,560 63,706 70,958 69,115 64,948 67,208 68,320 80,891 69,859
Book Value per Share
$103.51 $104.95 $100.84 $96.63 $95.52 $98.11 $105.27 $101.98 $98.89 $99.49 $90.12
Tangible Book Value per Share
($18.60) ($16.99) ($20.77) ($23.63) ($24.06) ($20.07) ($12.62) ($15.64) ($17.93) ($16.81) ($25.89)
Total Capital
29,151 29,982 29,437 29,007 28,965 28,581 29,721 29,282 28,906 27,117 25,746
Total Debt
14,167 14,692 14,689 14,706 14,742 13,786 13,793 13,796 13,770 11,805 11,803
Total Long-Term Debt
14,167 14,692 14,689 14,706 14,742 13,786 13,793 13,796 13,770 11,805 11,803
Net Debt
12,482 10,339 11,363 11,434 11,681 10,677 11,711 10,412 11,275 9,228 10,137
Capital Expenditures (CapEx)
256 816 361 320 270 803 359 304 309 632 296
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2,387 -4,207 -2,095 -1,913 -1,397 -1,345 763 -1,072 -168 -1,676 -180
Debt-free Net Working Capital (DFNWC)
-702 146 1,231 1,359 1,664 1,764 2,845 2,312 2,327 901 1,486
Net Working Capital (NWC)
-702 146 1,231 1,359 1,664 1,764 2,845 2,312 2,327 901 1,486
Net Nonoperating Expense (NNE)
-4.16 -377 -59 -46 -50 260 -85 -16 -43 -1,311 -207
Net Nonoperating Obligations (NNO)
12,482 10,339 11,363 11,434 11,681 10,677 11,711 10,412 11,275 9,228 10,137
Total Depreciation and Amortization (D&A)
337 414 331 326 299 400 317 323 298 382 327
Debt-free, Cash-free Net Working Capital to Revenue
-5.91% -10.25% -5.11% -4.69% -3.48% -3.42% 1.97% -2.83% -0.45% -4.58% -0.51%
Debt-free Net Working Capital to Revenue
-1.74% 0.36% 3.00% 3.33% 4.15% 4.49% 7.35% 6.10% 6.27% 2.46% 4.22%
Net Working Capital to Revenue
-1.74% 0.36% 3.00% 3.33% 4.15% 4.49% 7.35% 6.10% 6.27% 2.46% 4.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.33 $8.66 $7.02 $6.37 $6.34 ($3.50) $6.20 $5.35 $5.52 $13.48 $5.92
Adjusted Weighted Average Basic Shares Outstanding
144.60M 147M 146.20M 147.50M 148.90M 151.50M 151.20M 151.70M 152.60M 154.90M 154.60M
Adjusted Diluted Earnings per Share
$3.32 $8.66 $7.00 $6.36 $6.32 ($3.49) $6.18 $5.34 $5.50 $13.42 $5.89
Adjusted Weighted Average Diluted Shares Outstanding
144.90M 147.30M 146.50M 147.70M 149.30M 152M 151.70M 152.20M 153.20M 155.60M 155.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
143.93M 144.76M 145.70M 146.25M 147.99M 150.04M 150.79M 151.30M 151.86M 153.05M 153.91M
Normalized Net Operating Profit after Tax (NOPAT)
477 887 967 894 894 -275 852 796 799 769 708
Normalized NOPAT Margin
5.04% 8.31% 9.68% 8.75% 8.82% -2.59% 8.71% 8.31% 8.59% 7.66% 7.90%
Pre Tax Income Margin
6.10% 14.51% 11.88% 11.22% 11.16% -7.12% 11.44% 10.31% 10.73% 24.44% 12.15%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.71 10.69 8.38 8.44 8.75 -0.38 8.93 7.71 8.74 21.43 9.93
NOPAT to Interest Expense
3.06 5.55 6.01 5.81 6.12 -0.50 6.04 5.41 6.19 6.40 5.81
EBIT Less CapEx to Interest Expense
3.06 5.59 6.14 6.36 6.90 -1.84 6.38 5.65 6.34 16.17 7.51
NOPAT Less CapEx to Interest Expense
1.42 0.45 3.77 3.73 4.27 -1.96 3.49 3.34 3.80 1.14 3.38
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
32.47% 28.41% 49.22% 50.22% 52.32% 54.28% 23.55% 23.38% 22.39% 21.49% 18.68%
Augmented Payout Ratio
81.08% 88.64% 151.07% 151.75% 143.47% 127.24% 58.81% 61.99% 62.30% 52.21% 54.72%

Frequently Asked Questions About Northrop Grumman's Financials

When does Northrop Grumman's financial year end?

According to the most recent income statement we have on file, Northrop Grumman's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Northrop Grumman's net income changed over the last 9 years?

Northrop Grumman's net income appears to be on an upward trend, with a most recent value of $4.17 billion in 2024, rising from $1.99 billion in 2015. The previous period was $2.06 billion in 2023. Check out Northrop Grumman's forecast to explore projected trends and price targets.

What is Northrop Grumman's operating income?
Northrop Grumman's total operating income in 2024 was $4.37 billion, based on the following breakdown:
  • Total Gross Profit: $8.36 billion
  • Total Operating Expenses: $3.99 billion
How has Northrop Grumman revenue changed over the last 9 years?

Over the last 9 years, Northrop Grumman's total revenue changed from $23.53 billion in 2015 to $41.03 billion in 2024, a change of 74.4%.

How much debt does Northrop Grumman have?

Northrop Grumman's total liabilities were at $34.07 billion at the end of 2024, a 7.3% increase from 2023, and a 80.2% increase since 2015.

How much cash does Northrop Grumman have?

In the past 9 years, Northrop Grumman's cash and equivalents has ranged from $1.58 billion in 2018 to $11.23 billion in 2017, and is currently $4.35 billion as of their latest financial filing in 2024.

How has Northrop Grumman's book value per share changed over the last 9 years?

Over the last 9 years, Northrop Grumman's book value per share changed from 30.28 in 2015 to 104.95 in 2024, a change of 246.6%.



This page (NYSE:NOC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners